- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/02 - Drugs for disorders of the nervous system for peripheral neuropathies
Patent holdings for IPC class A61P 25/02
Total number of patents in this class: 2220
10-year publication summary
|
49
|
60
|
93
|
124
|
169
|
140
|
173
|
165
|
174
|
145
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2713 |
26 |
| Shionogi & Co., Ltd. | 840 |
22 |
| Daiichi Sankyo Company, Limited | 1881 |
21 |
| The Regents of the University of California | 20211 |
17 |
| Osaka University | 3394 |
17 |
| Vertex Pharmaceuticals Incorporated | 1626 |
15 |
| Mitsubishi Tanabe Pharma Corporation | 563 |
15 |
| Grünenthal GmbH | 563 |
14 |
| Kyoto University | 2838 |
14 |
| Bristol-myers Squibb Company | 4847 |
13 |
| Novartis AG | 10674 |
12 |
| Janssen Pharmaceutica N.V. | 3352 |
12 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3370 |
12 |
| Toray Industries, Inc. | 7009 |
11 |
| King's College London | 544 |
11 |
| Ono Pharmaceutical Co., Ltd. | 428 |
11 |
| Tenacia Biotechnology (Hong Kong) Co., Limited | 36 |
11 |
| Pfizer Inc. | 3388 |
10 |
| The Trustees of Columbia University in the City of New York | 3596 |
10 |
| Eurofarma Laboratorios S.A. | 37 |
10 |
| Other owners | 1936 |